Join us in Boston at the leading industry event focused on innovative linker and conjugation strategies for next-generation ADC development.
Philipp Ochtrop, Director of Chemistry at Tubulis, will give a talk on advancing ADC design through novel linker technologies. His presentation, “Unlocking Novel Payloads for Antibody-Drug Conjugates Through Targeted Delivery of Hydroxyl-Linked Drugs via Alco5” will highlight Tubulis’ approach to expanding the therapeutic potential of ADCs beyond current payload limitations.
